Insider trading · Q3 2026 · CIK 1498547

Cim Group, Inc. insider trading.

In Q3 2026, insiders at Cim Group, Inc. reported 5 non-derivative transactions on 8 Forms 3, 4 and 5: 1 open-market purchase worth $2.7M and 1 sale worth $110K.

Transactions
5
Purchases (P)
1
Sales (S)
1
Net shares, P minus S
505,391
Insiders
3
Last filed
2026-09-09

Insiders

InsiderRelationshipTransactionsBuysSales
Ressler Richard SDirector, Officer, TenPercentOwner · CEO & President310
Schreiber Jason KDirector101
Thompson David AndrewOfficer · See Remarks100

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-04Ressler Richard SP (A)526,808$5.14868,172Form 4
2026-09-04Schreiber Jason KS (D)21,417$5.1419,157Form 4
2026-06-30Ressler Richard SM (A)177,400—177,400Form 4
2026-06-30Ressler Richard SJ (D)177,400—0Form 4
2026-06-30Thompson David AndrewM (A)6,635—19,884Form 4

Transaction codes in this quarter

Get Cim Group, Inc. insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1498547&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · Cim Group, Inc. on SEC.gov

Questions

Are insiders buying or selling Cim Group, Inc.?

In Q3 2026, insiders at Cim Group, Inc. reported 5 non-derivative transactions on 8 Forms 3, 4 and 5: 1 open-market purchase worth $2.7M and 1 sale worth $110K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Cim Group, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/1498547.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.